Nelson Leung, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Nelson Leung, MD

Nelson Leung, MD

Healthcare Professional
Consultant
Division of Nephrology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Nelson Leung is a Nephrologist at Mayo Clinic, Minnesota. He completed his graduation from Santa Clara University and MD from Creighton University School of Medicine, followed by a Residency in Internal Medicine and Fellowship in Nephrology from Mayo Clinic College of Medicine. Dr. Nelson Leung has an experience in treating conditions like amyloidosis, kidney failure and monoclonal gammopathy of undetermined significance (MGUS).

Dr. Leung is interested in kidney diseases caused by monoclonal gammopathy and also diseases like immunoglobulin light chain amyloidosis, caused by the overproduction of immunoglobulin light chains that form amyloid fibrils. Dr. Leung’s work particularly revolves around improving current diagnostic techniques and redefining response criteria in amyloidosis patients.

 

Representative Publications:

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

Natural history of multiple myeloma with de novo del(17p)

Two types of amyloidosis presenting in a single patient: a case series 

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis 

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close